<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> FR89720-0103 </DOCNO><DOCID>fr.7-20-89.f2.A1102</DOCID><TEXT><ITAG tagnum="69"><ITAG tagnum="18">Drug Enforcement Administration</ITAG><ITAG tagnum="52">Quotas for Controlled Substances in Schedule II</ITAG><ITAG tagnum="10"><T2>AGENCY: </T2>Drug Enforcement Administration, Justice.</ITAG><ITAG tagnum="10"><T2>ACTION: </T2>Notice of established 1989 aggregate production quotas.</ITAG><ITAG tagnum="10"><T2>SUMMARY: </T2>This notice establishes revised 1989 aggregate productionquotas for controlled substances in Schedule II, as required under theControlled Substances Act of 1970.</ITAG><ITAG tagnum="10"><T2>DATE: </T2>This order is effective upon publication.</ITAG><ITAG tagnum="10"><T2>FOR FURTHER INFORMATION CONTACT:</T2>Howard McClain, Jr., Chief, DrugControl Section, Drug Enforcement Administration, Washington, DC 20537,Telephone: (202) 307-7183.</ITAG><ITAG tagnum="10"><T2>SUPPLEMENTARY INFORMATION: </T2>Section 306 of the Controlled SubstancesAct (21 U.S. Code 826) requires the Attorney General to establish aggregateproduction quotas for all controlled substances in Schedules I and II eachyear. This responsibility has been delegated to the Administrator of theDrug Enforcement Administration pursuant to Section 0.100 of Title 21 ofthe Code of Federal Regulations.On April 24, 1989, a notice of the proposed revised 1989 aggregate productionquotas for certain controlled substances in Schedule II was published inthe <T4>Federal Register </T4>(54 FR 16418). All interested parties were invitedto comment on or object to these proposed aggregate production quotas onor before May 24, 1989. No comments or objections were received.Pursuant to Sections 3(c)(3) and 3(e)(2)(C) of Executive Order 12291, theDirector of the Office of Management and Budget has been consulted withrespect to these proceedings.This action has been analyzed in accordance with the principles and criteriacontained in Executive Order 12612, and it has been determined that thismatter does not have sufficient federalism implications to warrant thepreparation of a Federalism Assessment.The Administrator hereby certifies that this matter will have no significantimpact upon small entities within the meaning and intent of the RegulatoryFlexibility Act, 5 U.S.C. 601 et seq. The establishment of annual aggregateproduction quotas for Schedules I and II controlled substances is mandatedby law and by the international commitments of the United States. Suchquotas impact predominantly upon major manufacturers of the affected controlledsubstances.Therefore, under the authority vested in the Attorney General by Section306 of the Controlled Substances Act of 1970 (21 U.S.C. 826) and delegatedto the Administrator of the Drug Enforcement Administration by Section0.100 of Title 28 of the Code of Federal Regulations, the Administratorof the Drug Enforcement Administration hereby orders that the 1989 revisedaggregate production quotas be established as follows:<ITAG tagnum="110"><C>2,L2,tp0,i1,s25,10</C> <H1>Basic class</H1><H1>Established revised 1989 aggregate production quotas (expressed asgrams of anhydrous acid or base)</H1>Schedule II:<ITAG tagnum="2">Amobarbital<D>160,000</D></ITAG><ITAG tagnum="2">Amphetamine<D>352,000</D></ITAG><ITAG tagnum="2">Codeine (for conversion)<D>5,194,000</D></ITAG><ITAG tagnum="2">Desoxyephedrine<D>1,487,000</D></ITAG><ITAG tagnum="3">Levodesoxyephedrine</ITAG><D>1,487,000</D><ITAG tagnum="3">Methamphetamine</ITAG><D>0</D><ITAG tagnum="2">Dextropropoxyphene<D>82,381,000</D></ITAG><ITAG tagnum="2">Dihydrocodeine<D>269,000</D></ITAG><ITAG tagnum="2">Diphenoxylate<D>948,000</D></ITAG><ITAG tagnum="2">Fentanyl<D>18,000</D></ITAG><ITAG tagnum="2">Hydrocodone<D>3,244,000</D></ITAG><ITAG tagnum="2">Hydromorphone<D>221,000</D></ITAG><ITAG tagnum="2">Levorphanol<D>11,000</D></ITAG><ITAG tagnum="2">Methadone<D>1,856,000</D></ITAG><ITAG tagnum="2">Methadone Intermediate<D>2,320,000</D></ITAG><ITAG tagnum="2">Methamphetamine (for conversion)<D>965,000</D></ITAG><ITAG tagnum="2">Mixed Alkaloids of Opium<D>7,000</D></ITAG><ITAG tagnum="2">Morphine (for sale)<D>3,634,000</D></ITAG><ITAG tagnum="2">Oxycodone (for sale)<D>2,452,000</D></ITAG><ITAG tagnum="2">Pentobarbital<D>13,219,000</D></ITAG><ITAG tagnum="2">Phenylacetone<D>1,198,000</D></ITAG><ITAG tagnum="2">Secobarbital<D>545,000</D></ITAG></ITAG><ITAG tagnum="21">Dated: June 26, 1989.</ITAG><ITAG tagnum="6">John C. Lawn,</ITAG><ITAG tagnum="4">Administrator, Drug Enforcement Administration.</ITAG><ITAG tagnum="40">[FR Doc. 89-16943 Filed 7-19-89; 8:45 am]</ITAG><ITAG tagnum="68">BILLING CODE 4410-09-M</ITAG></ITAG></ITAG></TEXT></DOC>